Soleil Securities is maintaining their Buy rating on Hologic (NASDAQ: HOLX) as the firm is expecting them to announce sales ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE